Back

Trials@Home

In this IMI-funded project, academia and pharmaceutical companies work together on  the definition and operationalisation of remote elements in clinical trials.

Trials@Home is a five-year project of the Innovative Medicines Initiative. Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.